Treatment of Type2 Diabetes

Providing Better Support for Diabetes Patients During COVID-19 Pandemic

COVID-19 is a serious threat to anyone with chronic health issues like diabetes; Promote #diabetesupport to help those who are at higher risk

We all know by now that COVID-19 (Corona Virus) is a serious public health threat.

We also know that older individuals and any individuals with serious chronic health issues like diabetes are at higher risk for complications, should they contract the virus. 

According to WHO, in China people with diabetes and/or other health issues, such as heart disease, had more serious complications from COVID-19 and a higher death rate

Individuals with diabetes already face daily challenges in managing their disease, including practicing sick day rules when ill and even being able to access or afford insulin and supplies.  This, coupled with the current public health advice to “stock up” on medications, practice social distancing and the knowledge that contracting COVID-19 puts them at great risk for DKA and other complications, is very stressful for both the individual with the disease and also their loved ones. 

 According to the CDC, 34.2 million  Americans have diabetes. At any given time, between 25-45% of hospitalized patients have diabetes and although the hospitalizations maybe for a condition other than diabetes, just having the disease and hyperglycemia puts them at greater risk for hospital-acquired infections, slower healing, longer lengths of stays, etc.  

Add COVID-19 to diabetes patients and their risk of other complications goes way up.   

Hospitals, outpatient practices, medical device firms, and the pharmaceutical industry can and should take action to provide extra care for those struggling right now.   I believe that all of us who work to care for individuals with diabetes have an obligation to provide even more care and support to them during this difficult time.   

Below are a few ideas; some are pretty basic and easy, while others are more costly and complex, but now is the time for all of us to get creative and share ideas and commit to implementing changes.  Please join us in promoting #diabetesupport throughout your organization and add your ideas and initiatives to the list!

The COVID-19 pandemic is challenging everyone and every institution, but we particularly owe the people we serve within the diabetes industry, the people who use our products and services, the people for whom our missions are built, more support during this time.  #diabetesupport

Laurel Fuqua, RN, MSN is the Executive Vice President and Chief Clinical Officer at Monarch Medical Technologies. As an accomplished executive and diabetes industry leader, Laurel draws from more than three decades of healthcare experience to lead the clinical vision and guide the product strategy at Monarch. She has held executive-level positions across a wide range of healthcare settings including, hospitals, health plans, care management, and diabetes technology firms. Prior to joining the company, Laurel served as the Senior Vice President of Clinical and Operations at Canary Health, a provider of digital health self-management programs. Previously, she was the Senior Vice President of Population Health, Clinical Affairs & Care Innovations for InSpark Technologies. She’s also held executive positions with Glytec, Alere, Inspiris, Kindred Healthcare, and Healthways, among others.

Related Articles

Back to top button